Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-14 5:32 pm Purchase | 2025-04-08 | 13G | AMERICAN REBEL HLDGS INC N AREB | Mitchell P. Kopin | 4 9.990% | 4 (New Position) | Filing History |
| 2025-04-09 5:31 pm Unchanged | 2025-04-03 | 13G | APTEVO THERAPEUTICS INC NE APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-07 4:17 pm Purchase | 2025-04-01 | 13G | GRI BIO INC PAR $0.0001 NE GRI | Mitchell P. Kopin | 1,438 4.990% | 1,438 (New Position) | Filing History |
| 2025-02-18 06:19 am Purchase | 2025-02-11 | 13G | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | Mitchell P. Kopin | 138,763 4.990% | 138,763 (New Position) | Filing History |
| 2025-02-11 4:53 pm Purchase | 2025-02-05 | 13G | 60 DEGREES PHARMACEUTICALS INC SXTP | Mitchell P. Kopin | 19,340 4.990% | 5,112 (+35.93%) | Filing History |
| 2025-02-11 4:51 pm Purchase | 2025-02-05 | 13G | MUSTANG BIO INC PAR $0.000 MBIO | Mitchell P. Kopin | 186,552 9.990% | 186,552 (New Position) | Filing History |
| 2025-02-05 5:15 pm Sale | 2025-01-30 | 13G | ENVERIC BIOSCIENCES INC PA ENVB | Mitchell P. Kopin | 8,663 4.990% | -15,504 (-64.15%) | Filing History |
| 2025-02-05 5:13 pm Purchase | 2025-01-30 | 13G | SAVERONE 2014 LTD ADS REPSTG O SVRE | Mitchell P. Kopin | 75,768 4.990% | 75,768 (New Position) | Filing History |
| 2025-02-03 4:05 pm Purchase | 2025-01-28 | 13G | 60 DEGREES PHARMACEUTICALS INC SXTP | Mitchell P. Kopin | 14,228 4.990% | 14,228 (New Position) | Filing History |
| 2025-01-28 5:25 pm Purchase | 2025-01-23 | 13G | DERMATA THERAPEUTICS INC P DRMA | Mitchell P. Kopin | 26,247 6.700% | 25,287 (+2634.06%) | Filing History |
| 2025-01-27 06:14 am Sale | 2025-01-21 | 13G | COLOR STAR TECHNOLOGY CO LTD ADD | Mitchell P. Kopin | 20,180 9.990% | -65,583 (-76.47%) | Filing History |
| 2025-01-21 5:49 pm Purchase | 2025-01-15 | 13G | SILEXION THERAPEUTICS CORP SLXN | Mitchell P. Kopin | 13,988 4.990% | 13,988 (New Position) | Filing History |
| 2025-01-17 4:44 pm Purchase | 2025-01-13 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 530,171 9.990% | 439,184 (+482.69%) | Filing History |
| 2025-01-16 6:34 pm Purchase | 2025-01-12 | 13G | NAYA BIOSCIENCES, INC. NAYA | Mitchell P. Kopin | 42,040 6.900% | 26,707 (+174.18%) | Filing History |
| 2025-01-15 4:03 pm Sale | 2024-12-31 | 13G | PHARMACYTE BIOTECH INC PMCB | Mitchell P. Kopin | 714,844 9.990% | -78,903 (-9.94%) | Filing History |
| 2025-01-14 5:49 pm Purchase | 2025-01-07 | 13G | REWALK ROBOTICS LTD SHARE LFWD | Mitchell P. Kopin | 46,152 4.990% | 17,756 (+62.53%) | Filing History |
| 2025-01-14 5:45 pm Unchanged | 2025-01-08 | 13G | MYSEUM INC MYSE | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-01-10 6:53 pm Purchase | 2025-01-06 | 13G | MICROBOT MED INC MBOT | Mitchell P. Kopin | 2,672,084 8.800% | 2,672,084 (New Position) | Filing History |
| 2025-01-10 6:51 pm Purchase | 2025-01-06 | 13G | BIOLINERX LTD SPONSORED ADR NE BLRX | Mitchell P. Kopin | 2,555,903 4.990% | 2,555,671 (+1101582.33%) | Filing History |
| 2025-01-03 8:08 pm Purchase | 2024-12-27 | 13G | ETHZILLA CORPORATION ETHZ | Mitchell P. Kopin | 16,529 4.990% | 16,529 (New Position) | Filing History |